MAPT and Alzheimer disease: The glutamaergic pathway includes proteins known to be part of the causal AD pathways such as another proteoforms of calcineurin (PPP3R1) reported to be associated with phosphor-tau levels and rate of memory decline,56 or HOMER1.58.